Kainos Medicine, Inc. (KOSDAQ: 284620)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,225.00
-40.00 (-1.23%)
Dec 20, 2024, 12:32 PM KST

Kainos Medicine Statistics

Total Valuation

Kainos Medicine has a market cap or net worth of KRW 94.55 billion.

Market Cap 94.55B
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Kainos Medicine has 28.18 million shares outstanding.

Current Share Class n/a
Shares Outstanding 28.18M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 10.53%
Owned by Institutions (%) n/a
Float 25.21M

Valuation Ratios

The trailing PE ratio is 2,368.42.

PE Ratio 2,368.42
Forward PE n/a
PS Ratio n/a
PB Ratio 0.91
P/TBV Ratio 4.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 0.20% and return on invested capital (ROIC) is 0.19%.

Return on Equity (ROE) 0.20%
Return on Assets (ROA) n/a
Return on Capital (ROIC) 0.19%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.09% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -28.09%
50-Day Moving Average 3,903.30
200-Day Moving Average 4,015.38
Relative Strength Index (RSI) 53.63
Average Volume (20 Days) 526,359

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income 60.74M
Pretax Income 60.74M
Net Income 39.92M
EBITDA n/a
EBIT 60.74M
Earnings Per Share (EPS) 6.18
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) 19.83B
Book Value Per Share 3,672.38
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow 169.79M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Kainos Medicine does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,474.97%
Shareholder Yield -1,474.97%
Earnings Yield 0.18%
FCF Yield n/a

Stock Splits

The last stock split was on June 24, 2022. It was a reverse split with a ratio of 0.2.

Last Split Date Jun 24, 2022
Split Type Reverse
Split Ratio 0.2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a